HELP
Helus Pharma Inc. Health Care Pharmaceutical Preparations Russell 3000
$10.60Close
$3.87 – $14.0252-week range
Nov 12, 2026Next report
Highlights
Strengths
- Leading the market RS 94 · stronger than 94% of stocks over 12 months
Cautions
- Trend not confirmed 7 of 8 conditions · under the 50-day
- Results soon Nov 12, 2026, in 11 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Trade setup
ATR%
8.1%
$0.86 a day · 2×ATR $8.88
RS
94 / 99
vs the universe
Trend
7 / 8
under the 50-day
Relative volume
0.7×
vs 50-day average
Up/down volume
0.92
50 sessions
Implied move
—
no option chain · report Nov 12, 2026
Contractions
3
33% → 22% → 17%
Pivot
$11.74
9.8% below
Volume dry-up
0.8×
10 vs 50 sessions
Trend template · 7 of 8
- Price above the 50-day average: fails
Screen verdict
Not scorable — no classified balance sheet.
Last shock
Aug 10, 2026-14% in one session1.9× volumeno filing matched+6% since
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Jul 1, 2025 | Annual ↗ | — | 0d |
| Jun 26, 2024 | Annual ↗ | — | 0d |
| Jun 27, 2023 | Annual ↗ | — | 0d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 27, 2026 | Foreign issuer report ↗ |
| Oct 21, 2026 | Foreign issuer report ↗ |
| Oct 15, 2026 | Foreign issuer report ↗ |
| Oct 8, 2026 | Foreign issuer report ↗ |
| Oct 5, 2026 | Foreign issuer report ↗ |
| Oct 2, 2026 | Foreign issuer report ↗ |
| Oct 1, 2026 | Foreign issuer report ↗ |
| Sep 23, 2026 | Foreign issuer report ↗ |
| Sep 22, 2026 | Foreign issuer report ↗ |
| Sep 21, 2026 | Foreign issuer report ↗ |
| Sep 10, 2026 | Foreign issuer report ↗ |
| Sep 9, 2026 | Foreign issuer report ↗ |